|
Sbrt±sTad for Unfavorable iNtermediate rIsk/High Risk Prostate caNcer
RECRUITINGPhase 2Sponsored by Regina Elena Cancer Institute
Actively Recruiting
PhasePhase 2
SponsorRegina Elena Cancer Institute
Started2021-02-02
Est. completion2024-02-02
Eligibility
Age18 Years – 90 Years
SexMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT05557604
Summary
This is a prospective, open, randomized phase II trial.
Eligibility
Age: 18 Years – 90 YearsSex: MALEHealthy volunteers accepted
Inclusion Criteria: * Histologically proven prostate adenocarcinoma * IR or HR in the NCCN definition * N0M0 at staging with choline or (preferably) PSMA PET-CT; * ECOG performance status between 0 and 2; Exclusion Criteria: * Previous local treatment of the prostate with surgery (radical prostatectomy or cryotherapy) * Previous radiotherapy to the pelvis * Previous chemotherapy for malignancy in past 5 years * Impossibility to implant fiducials for tracking purposes * Impossibility to undergo MRI of the prostate * Contraindication to short term AD * Prostate volume \>90cc
Conditions2
CancerProstate Cancer
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
Actively Recruiting
PhasePhase 2
SponsorRegina Elena Cancer Institute
Started2021-02-02
Est. completion2024-02-02
Eligibility
Age18 Years – 90 Years
SexMALE
Healthy vol.Accepted
View on ClinicalTrials.gov →
NCT05557604